Mirum Pharmaceuticals, Inc. (MIRM) vs Rhythm Pharmaceuticals, Inc. (RYTM)
Mirum Pharmaceuticals, Inc. and Rhythm Pharmaceuticals, Inc. are both Biotechnology companies. Rhythm Pharmaceuticals, Inc. is the larger, with a market value of $6.8B against $5.8B — 1.2× the size. Rhythm Pharmaceuticals, Inc. grew revenue faster over the last twelve months: 53.5% against 44.0%. Rhythm Pharmaceuticals, Inc. has the higher net margin (−87.6% vs −139.2%) and the higher return on invested capital (0.00% vs −173.0%). Across the 16 metrics below, Rhythm Pharmaceuticals, Inc. leads on 11 and Mirum Pharmaceuticals, Inc. on 5.
Valuation
Profitability
| Metric | MIRM | RYTM | Biotechnology median |
|---|---|---|---|
| Gross margin | 81.72% | 89.00% | 65.16% |
| Operating margin | (134.93%) | (83.62%) | 0.00% |
| Net margin | (139.18%) | (87.62%) | 0.00% |
| Free cash flow margin | (44.29%) | (43.91%) | 0.00% |
| Return on equity | (702.97%) | (461.65%) | (57.72%) |
| Return on assets | (97.15%) | (51.91%) | (49.22%) |
| Return on invested capital | (172.96%) | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack